Retour
24
Également cotée sous
HAWPF
OTC
Fourchette du Jour
53,50 €
54,44 €
Fourchette 52 Semaines
28,64 €
54,44 €
Volume
7
Moyenne 50J / 200J
50,64 €
/
46,09 €
Clôture Précédente
53,50 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 11,3 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | 6,2 | 3,7 |
| Net Margin % | 115,4 | 3,8 |
| Rev Growth 5Y % | 12,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 12,52% annually over 5 years — strong growth
Net margin of 115,43% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 264,87M in free cash flow
P/E of 11,34 — trading at a low valuation
PEG of 0,95 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
12,52%
Revenue (1Y)-7,57%
Earnings (1Y)14,43%
FCF Growth (3Y)119,62%
Qualité
Return on Equity
6,19%
ROIC1,14%
Net Margin115,43%
Op. Margin29,17%
Sécurité
Debt / Equity
0,01
Current Ratio7,13
Interest Coverage44,05
Valorisation
P/E Ratio
11,34
P/B Ratio0,69
EV/EBITDA33,54
Dividend Yield0,08%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -7,57% | Revenue Growth (3Y) | -1,25% |
| Earnings Growth (1Y) | 14,43% | Earnings Growth (3Y) | 9,83% |
| Revenue Growth (5Y) | 12,52% | Earnings Growth (5Y) | 24,11% |
| Profitability | |||
| Revenue (TTM) | 226,29M | Net Income (TTM) | 261,22M |
| ROE | 6,19% | ROA | 5,91% |
| Gross Margin | 55,99% | Operating Margin | 29,17% |
| Net Margin | 115,43% | Free Cash Flow (TTM) | 264,87M |
| ROIC | 1,14% | FCF Growth (3Y) | 119,62% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 7,13 |
| Interest Coverage | 44,05 | Dividend Yield | 0,08% |
| Valuation | |||
| P/E Ratio | 11,34 | P/B Ratio | 0,69 |
| P/S Ratio | 13,08 | PEG Ratio | 0,95 |
| EV/EBITDA | 33,54 | Dividend Yield | 0,08% |
| Market Cap | 2,96B | Enterprise Value | 2,21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 226,29M | 244,82M | 232,06M | 182,09M | 141,18M |
| Net Income | 261,22M | 228,27M | 216,57M | 148,32M | 110,10M |
| EPS (Diluted) | 4,72 | 4,12 | 3,92 | 2,68 | 2,00 |
| Gross Profit | 126,71M | 134,09M | 134,89M | 98,57M | 73,64M |
| Operating Income | 66,02M | 63,84M | 64,01M | 43,38M | 24,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,42B | 4,28B | 3,59B | 3,65B | 3,28B |
| Total Liabilities | 126,80M | 128,47M | 117,18M | 101,41M | 72,09M |
| Shareholders' Equity | 4,29B | 4,15B | 3,48B | 3,55B | 3,21B |
| Total Debt | 44,26M | 36,30M | 28,48M | 58,40M | 1,52M |
| Cash & Equivalents | 791,26M | 745,78M | 574,01M | 334,27M | 596,23M |
| Current Assets | 897,97M | 4,01B | 3,28B | 380,58M | 642,08M |
| Current Liabilities | 125,93M | 127,66M | 116,41M | 100,50M | 71,19M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#690 of 820
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026